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Introduction
During the last decade, several studies have investigated ab-
normal retinal and cortical visual processing in major depres-
sive disorder (MDD). Retinal processing in MDD has been 
assessed using pattern electroretinogram (PERG; for reviews, 
see Schwitzer and colleagues1,2), and some studies revealed 
that the slope of the increase in PERG signal amplitude as a 
function of contrast is lower in people with MDD than con-
trols, suggesting reduced retinal contrast gain in people with 
MDD.3 Lower retinal gain indicates that a weaker contrast 
signal is being sent from the retina to the cortex and it may 
cause changes in perceptual experience. Physiologic changes 
in retinal processing have been associated with elevated 
 contrast-detection thresholds measured with behavioural 
tests;4 this abnormality returned to normal after successful 
therapy intervention.5 However, some studies have not re-
vealed a difference in PERG findings, although participant 
groups differed in contrast sensitivity.6 Cortical electro-
encephalogram (EEG) responses to checkerboard stimuli at 
occipital electrodes was also reduced in patients with MDD 
compared to controls.7 The lower PERG and EEG amplitudes 
and higher contrast-detection thresholds suggest that the 
subjective perceptual experience is also changed in MDD. 
However, the subjective perception of contrast in MDD has 
not been assessed before. In addition to contrast perception, 
other changes in visual processing have been reported in 
MDD. Two studies that used behavioural measurements to 
evaluate the cortical processing of visual motion and contour 
integration found increased suppression of visual motion8 
and decreased integration of nearby collinear elements9 in 
people with MDD.
The physiology and neural processes of the visual system 
have been extensively studied and are well known; as a result, 
studying changes in patients’ visual processing might provide 
insights into the neural mechanisms of MDD. Concentration 
of neurotransmitters, neural plasticity and connectivity to 
other areas differ in the retinal and cortical circuits; character-
izing deficits at different levels of processing might have im-
plications for our understanding of the causes and treatment 
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Background: Previous studies have suggested that processing of visual contrast information could be altered in major depressive disor-
der. To clarify the changes at different levels of the visual hierarchy, we behaviourally measured contrast perception in 2 centre-surround 
conditions, assessing retinal and cortical processing. Methods: As part of a prospective cohort study, our sample consisted of controls 
(n = 29; 21 female) and patients with unipolar depression, bipolar disorder and borderline personality disorder who had baseline major 
depressive episodes (n = 111; 74 female). In a brightness induction test that assessed retinal processing, participants compared the per-
ceived luminance of uniform patches (presented on a computer screen) as the luminance of the backgrounds was varied. In a contrast 
suppression test that assessed cortical processing, participants compared the perceived contrast of gratings, which were presented with 
collinearly or orthogonally oriented backgrounds. Results: Brightness induction was similar for patients with major depressive episodes 
and controls (p = 0.60, d = 0.115, Bayes factor = 3.9), but contrast suppression was significantly lower for patients than for controls 
(p < 0.006, d = 0.663, Bayes factor = 35.2). We observed no statistically significant associations between contrast suppression and age, 
sex, or medication or diagnostic subgroup. At follow-up (n = 74), we observed some normalization of contrast perception. Limitations: 
We assessed contrast perception using behavioural tests instead of electrophysiology. Conclusion: The reduced contrast suppression 
we observed may have been caused by decreased retinal feedforward or cortical feedback signals. Because we observed intact bright-
ness induction, our results suggest normal retinal but altered cortical processing of visual contrast during a major depressive episode. 
This alteration is likely to be present in multiple types of depression and to partially normalize upon remission.
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of MDD. Although the literature suggests that visual process-
ing may be altered in MDD, whether the deficit is in retinal 
or cortical processing (or both) is not yet fully understood. 
A purely retinal deficit would indicate more local changes in 
the processing of visual information; a cortical deficit could 
indicate more widespread abnormality.
Visual contrast perception can be understood as a hier-
archical sequence of normalization processes that discount 
environmental variability and optimize neural processing.10 
In the retina, the centre-surround organization of the recep-
tive fields of ganglion cells11 discounts the effect of prevailing 
luminance and enables lightness constancy. This process en-
hances the role of contrast borders and is perceptually visible 
in several visual illusions, such as simultaneous contrast, in 
which identical central patches appear different in lightness 
or brightness because of different border contrasts between 
the centre and the surround.12–16 This effect of surround lumi-
nance on brightness is often referred to as brightness induc-
tion; it occurs before binocular fusion and is found immedi-
ately after congenitally blind vision has been surgically 
restored.16 Reduced retinal contrast gain in MDD could lead 
to reduced strength of the brightness induction illusion.
In the primary visual cortex, the neurons optimally re-
spond to contrast patterns at a certain orientation and at a 
certain spatial scale.17–19 In addition, neural activity is di-
vided by the pooled activity of the surrounding neurons, 
causing surround suppression.20–23 When a small luminance-
modulated patch is embedded on a larger, similarly modu-
lated patch with higher contrast, surround suppression is 
visible in reduced perceived contrast of the central patch.24 
Importantly, contrast suppression is specific to orientation; 
there is no suppression if the centre and surround have 
 orthogonal orientations. This suggests a cortical compon-
ent of the surround effect, because the primary visual cortex 
is the first level of the visual processing hierarchy to con-
tain orientation-specific mechanisms. Therefore, surround 
suppression involves 2 components — retinal feedforward 
and cortical feedback signals — that have different thresh-
olds and gains. In MDD, both reduced retinal contrast gain 
and changes in cortical processing could change the 
strength of the contrast suppression illusion.
The findings of electrophysiological and behavioural as-
sessments of contrast perception in MDD have been inconsis-
tent, and most previous behavioural studies have measured 
contrast detection at threshold. In the present study, we as-
sessed the subjective perceptual appearance of contrast pat-
terns. Furthermore, the retinal and cortical processing of con-
trast has not been compared in the same sample of patients. 
To clarify the role of different levels of contrast processing 
during major depressive episodes (MDEs), we undertook 
psycho physical measurement of the amount of brightness in-
duction and contrast suppression in patients experiencing an 
MDE and compared those to the contrast perception of con-
trol participants. Because brightness induction appears to be 
linked to low-level visual processing (e.g., retinal ganglion 
cells) and contrast suppression includes an orientation-
specific cortical component, we can assess contrast process-
ing behaviourally at different levels of the visual hierarchy. 
Understanding changes in visual processing may provide 
insight into putatively abnormal cortical information process-
ing during MDEs and open up opportunities to develop easily 
accessible biomarkers for changes in visual processing in 
depression. We also replicated the contrast tests in a follow-
up measurement at 7 months and tested whether contrast test 
scores normalized upon remission of the depression.
Methods
Participants
Patients were recruited from Helsinki City psychiatric out-
patient facilities. Briefly, we first screened 1655 referrals of 
patients (2013 to 2016) with a probable MDE. Based on strati-
fication by probable principal diagnosis, we then inter-
viewed 155 patients and recruited 124 patients who fulfilled 
all of the inclusion criteria (score ≥ 15 on the Montgomery–
Åsberg Depression Rating Scale [MADRS]; age 18–50 years) 
and none of the exclusion criteria. For more details of the re-
cruitment process, the inclusion and exclusion criteria, and 
detailed statistics, please see SÖderholm and colleagues25 
and Socada and colleagues.26 We further excluded 13 pa-
tients because they did not successfully complete the visual 
contrast tests. Altogether, we assessed 111 patients and 
29 controls. We tested 74 patients again in follow-up meas-
urements after 7 months.
The MDE patient group was divided into 3 subcohorts ac-
cording to their principal diagnosis: unipolar MDD (n = 46); 
bipolar disorder with a current MDE (n = 38); and borderline 
personality disorder with a current MDE (n = 27). Diagnoses 
of unipolar MDD and bipolar disorder were based on the 
Structured Clinical Interview for DSM-IV Axis I Disorders 
(SCID-I); diagnosis of borderline personality disorder was 
based on the Structured Clinical Interview for DSM-IV Axis 
II Disorders (SCID-II). We found excellent inter-rater reliabil-
ity (κ 0.898–1.0) in videotaped interviews.
In addition to the MADRS, other measures used included 
the Social and Occupational Functioning Assessment 
Scale, the Young Mania Rating Scale and modification of the 
bipolar specifier.27 We assessed symptoms of borderline per-
sonality disorder using the Borderline Personality Disorder 
Severity Index-IV.28 Patients completed several self-rating 
scales, including the Alcohol Use Disorders Identification 
Test, the Beck Depression Inventory II, the Beck Hopeless-
ness Scale, the Overall Anxiety Severity and Impairment 
Scale, the McLean Screening Instrument for Borderline Per-
sonality Disorder and the SCID-II screen. Inclusion criteria 
included no uncorrected hearing or vision impairment. 
Control participants were health care services personnel 
from the City of Helsinki; most were nurses. Controls were 
demographically matched to the patients. They were inter-
viewed using SCID-I and the SCID-II borderline personality 
disorder section. The inclusion criteria for controls were as 
follows: age 18–50 years, sufficient proficiency in the Finnish 
language and no uncorrected hearing or vision impairment. 
The exclusion criteria for controls were as follows: a lifetime 
MDE, bipolar disorder, any current psychiatric disorder, 
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a  substance use disorder, any current excessive substance 
use (alcohol or recreational drugs), or current use of any 
 psychopharmaceuticals.
Written informed consent was collected from each patient 
and control participant. The study was conducted according 
to the guidelines of the Declaration of Helsinki and was ap-
proved by the Ethics Committee of the Helsinki and Uusimaa 
Hospital District and the research board of the Health and 
Social Department of the City of Helsinki.
Stimuli
The stimuli were simple visual patterns presented in centre-
surround organization. In the brightness induction test, an un-
modulated luminance patch was surrounded by a larger 
 unmodulated background with lower or higher luminance 
than the centre patch (Figure 1, top). The centre and surround 
had a small (low Weber contrast, 5%) or large (high Weber 
contrast, 30%) differences in luminance. In the contrast sup-
pression test, the sine-wave modulated luminance patch was 
surrounded by a larger, similarly modulated surround, or it 
was presented without a surround. The surround had high 
contrast (60% Michelson contrast) and was either collinear or 
orthogonal relative to the centre patch (Figure 1, bottom), 
which always had low contrast (20% Michelson contrast). The 
stimuli were displayed on a laptop computer (HP Probook 
4540, 15.6-inch LED, resolution 1366 × 768) with equal screen 
resolution and brightness settings in standard office lighting.
Procedure
The perceived luminance and perceived contrast of the 
stimu li were measured using a standard 1-interval 1–1 adap-
tive staircase method with a 2-alternative forced-choice task 
(for a similar method, see Schallmo and colleagues29). 
During each trial of the brightness induction test, partici-
pants saw a pair of unmodulated centre-surround stimuli and 
were required to choose which centre patch (left or right) ap-
peared brighter. Two series were randomly interleaved: a test 
patch on a darker surround was kept constant and the com-
parison patch on the lighter surround was varied; or a test 
patch on a lighter surround was kept constant and the com-
parison patch of the darker surround was varied. The light or 
dark surround was randomly positioned on the left or right 
Fig. 1: Brightness induction and contrast suppression tests. Top: Brightness induction refers to the effect of surround luminance on 
centre brightness (i.e., perceived luminance). The centre patches A and B are equal in luminance, but they appear different in bright-
ness because of the difference in background luminance. A dark background enhances brightness; a bright background decreases 
brightness. Bottom: Contrast suppression refers to the effect of background on the apparent contrast of the centre. The centre patches 
C and D have identical contrast, but the contrast of C appears to be reduced or suppressed because of the collinear background. The 
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side of the display. After each “brighter” response, the lumi-
nance of the comparison patch was decreased (3%), and after 
each “darker” response, the luminance was increased (3%). 
In the contrast suppression test, participants were asked to 
choose the patch that appeared to be higher in contrast. 
A test patch was embedded in a collinear or orthogonal sur-
round, and a comparison patch was presented without a sur-
round. The test and comparison patches were always in ver-
tical orientation. The test and comparison stimuli appeared 
randomly on the left or right side of the display. Each 
“higher” response decreased (3%) the contrast of the compar-
ison patch, and each “lower” response increased (3%) the 
contrast of the comparison patch. 
Because of the adaptive method in both tests, the perceived 
luminance or contrast of the centre patches became perceptu-
ally indistinguishable and reached the point of subjective 
 simultaneity, in which the participant could not tell the differ-
ence between the patches. We used these points of subjective 
simultaneity as a measure of perceived contrast. Both tests 
contained 4 blocks (2 repetitions of low or high and collinear 
or orthogonal conditions) measured in random order. Each 
block contained 30 trials. The procedure included 8 measure-
ment series in total, each containing 15 trials. Brightness in-
duction and contrast suppression were measured at baseline 
for both patients and controls. Most patients repeated the 
measurements at follow-up (31 weeks after the baseline as-
sessment, on average). This was an observational study, and 
participants in the patient group received their usual psychi-
atric outpatient treatment between measurements. 
Data analysis
We calculated the mean of the last 4 trials for each series and 
used it as the measure of perceived contrast or luminance. 
We calculated the strength of brightness induction as the dif-
ference of the perceived luminance of the test patches embed-
ded in the light and dark surround divided by the sum of the 
perceived luminance of the patches (Figure 1; [A−B]/[A+B]). 
The strength of contrast suppression was similarly calculated 
as the difference of the perceived contrast of the test patches 
embedded in the collinear and orthogonal surround divided 
by the sum of the perceived contrasts of the test patches (Fig-
ure 1; [D−C]/[D+C]). Patient outliers (those with contrast 
suppression or brightness induction more than 3 standard 
deviations above or below the mean of all patients) were ex-
cluded from the analyses. We found 7 outlier data points at 
baseline (6 in brightness induction and 1 in contrast suppres-
sion tests) and 4 outliers at follow-up (all in brightness induc-
tion tests). No control data were excluded as outliers. 
We tested the differences between subgroups (controls and 
patients, comorbid diagnoses, medication and remission [no 
MDE criterion symptoms] at follow-up) using the χ2 test, the 
2-sample Welch t test, the Bayesian t test and analysis of vari-
ance. We used the Welch t test because it takes into account 
unequal sample sizes. Although the diagnostic subgroups 
did not differ significantly from controls in terms of sex dis-
tribution, we adjusted the test scores for age and sex because 
we found some trends for differences. We adjusted the 
brightness induction and contrast suppression scores by con-
ducting 2 linear regression analyses, using age and sex as ex-
planatory variables and the residuals of the analyses as 
 adjusted scores. We conducted a linear regression analysis to 
test whether the contrast suppression score was associated 
with age, sex, comorbid disorders or personality traits. We 
also performed 2 linear regression analyses to test the effect 
of different medications on brightness induction and contrast 
suppression. In these analyses the explanatory variables were 
age, sex and medications. 
Results
Participant characteristics are shown in Table 1. As noted 
above, we assessed 111 patients and 29 controls at baseline, 
and we tested 74 patients again in follow-up measurements 
after 7 months. We found no differences between groups in 
terms of race or sex, but the education level of controls was 
slightly higher, and their employment status was better 
(100%, v. 27%). We measured perceived contrast with 
2 centre-surround tests. We observed no differences between 
patients and controls in the brightness induction test 
(t39.8 = 0.534, p = 0.60, d = 0.115; Figure 2A), but we did ob-
serve a highly significant difference between groups in the 
contrast suppression test (t35.2 = 2.902, p = 0.006, d = 0.663; Fig-
ure 2B). Contrast suppression was reduced in patients com-
pared to controls; the strength of the illusion was lower for 
patients than for controls, and patients saw the stimuli as 
more veridical than controls did. To further confirm that this 
finding was due to suppression in the collinear condition and 
not to enhancement in the orthogonal condition, we com-
pared the perceived contrast in these conditions separately. 
The groups differed significantly in the collinear condition 
(t131 = 2.80, p  =  0.006), but not in the orthogonal condition 
(t131 = 1.55, p = 0.12), confirming the main results. Because the 
probability of the null hypothesis (a similar result between 
groups in brightness induction) could not be assessed with 
frequentist statistics (such as t tests), we conducted Bayesian t 
tests for group differences. Bayesian statistics further sup-
ported the results, and the Bayes factor (BF) provided posi-
tive evidence for similar results in the brightness induction 
test (BF01 = 3.9) and strong evidence for difference in the con-
trast suppression test (BF10 = 35.2). These findings further 
confirmed that patients saw the brightness induction illusion 
(Figure 2A) similarly to controls but saw the contrast sup-
pression illusion (Figure 2B) more veridically than controls. 
Because contrast suppression illusion depends on orientation 
(and this involves cortical computation) but the brightness 
induction illusion does not, our results suggest that patients 
and controls did not differ in the processing of contrast sig-
nals, but they did differ in how the contrast signal was pro-
cessed or normalized in the visual cortex.
The differences between the 2 tests were the stimulus (uni-
form patch v. modulated patch) and the perceptual task. Spe-
cifically, in the brightness induction test participants com-
pared brightness, and in the contrast suppression test they 
compared contrast. All other aspects of the tests, as well as 
the overall structure, were identical. Both tests included a 
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comparison of 2 patches of the same size on the same display; 
the same number of trials and blocks; and an identical adap-
tive staircase method. Therefore, because patients and con-
trols performed similarly in the brightness induction test, we 
could exclude all general and cognitive differences between 
groups (such as age, intelligence and vigilance) as causes for 
the specific difference in contrast suppression. We further 
confirmed this finding with a linear regression analysis, 
which failed to explain the variance in contrast suppression 
using age, sex, patient subgroups, medication, alcohol con-
sumption and the big 5 personality traits (extroversion, 
conscientiousness, openness, agreeableness and neuroticism; 
F11,80 = 1.105, p = 0.37, R2 = 0.132). In the nonsignificant model, 
only the use of mood stabilizers (p = 0.02) was associated 
with contrast suppression scores.
To further test the effect of medication and diagnosis on 
the amount of brightness induction and contrast suppression, 
we divided the patient group into 3 diagnostic subgroups 









Baseline 111 46 38 27 29
F/M 74/37 27/19 27/11 20/7 21/8
Follow-up 74 33 24 17 —
Sex
χ2* — 3.75 0.60 0.37 —
p value — 0.053 0.44 0.54 —
Age, yr, mean ± SD — 31.8 ± 10.1 32.0 ± 9.3 28.0 ± 7.3 32.1 ± 9.0
t† — t62.0 = 0.30 t58.1 = 0.22 t53.0 = 1.63 —
p value — 0.76 0.83 0.11 —
MADRS score, mean ± SD — 24.0 ± 6.2 21.7 ± 7.0 22.2 ± 6.5 2.3 ± 3.5
t† — t76.0 = 19.6 t65.5 = 15.6 t46.7 = 15.1 —
p value — < 0.001 < 0.001 < 0.001 —
YMRS score, mean ± SD — 1.70 ± 2.66 3.44 ± 3.70 3.55 ± 2.62 0.74 ± 1.61
t† — t73.94 = 1.97 t62.0 = 4.20 t50.64 = 4.99 —
p value — 0.053 < 0.001 < 0.001 —
F = female; M = male; MADRS = Montgomery–Åsberg Depression Rating Scale; SD = standard deviation; YMRS = Young Mania Rating Scale.
*χ2 test difference versus controls.
†t test difference versus controls.
Fig. 2: (A) We observed no difference in brightness induction between patients experiencing an MDE and controls (i.e., the per-
ceptual difference between patches A and B in Figure 1 was similar for both groups). (B) We observed a highly significant differ-
ence in contrast suppression between patients experiencing an MDE and controls (i.e., the perceptual difference between 
patches C and D in Figure 1 was larger for controls than for patients). Error bars depict standard errors of the mean. MDE = 
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and compared those with the control group. We found no 
significant differences between the diagnostic subgroups 
(brightness induction: F2,104 = 1.014, p = 0.37; contrast suppres-
sion: F2,107 = 1.043, p = 0.36), showing that in all subgroups 
brightness induction was intact (Figure 3A, top) but contrast 
suppression was reduced (Figure 3A, bottom). We further 
confirmed this finding in pair-wise t tests comparing the pa-
tient subgroups and controls (brightness induction: border-
line personality disorder t50 = –0.19, p = 0.85, bipolar disorder 
t62 = 1.14, p = 0.26, MDD t67 = 0.28, p = 0.78; contrast suppres-
sion: borderline personality disorder t52 = 2.66, p = 0.01, bipo-
lar disorder t62 = 2.71, p = 0.009, MDD t71 = 2.06, p = 0.04).
We also divided the patient group into 3 subgroups based 
on their medication use (Table 2) and compared those sub-
groups with patients taking no medication. The 3 medication 
subgroups partially overlapped because many patients were 
taking multiple medications. The correlations between 
groups were as follows: mood stabilizer and antipsychotic 
r = 0.188, p = 0.037; mood stabilizer and antidepressant r = 
–0.019, p = 0.84; antipsychotic and antidepressant r = –0.152, 
p = 0.09. Only the use of mood stabilizers had a small but sig-
nificant effect (F1,104 = 6.024, p = 0.016, η2 = 0.053) of increasing 
brightness induction (Figure 3B, top) and further decreasing 
contrast suppression (Figure 3B; bottom). However, in pair-
wise comparisons the effect of mood stabilizers was not sig-
nificant (contrast suppression: t17.26 = −2.095, p = 0.051; bright-
ness induction: t16.46 = 1.269, p = 0.22), although we did 
observe a trend for contrast suppression. In a linear regres-
sion analysis, the use of lamotrigine, valproate or pregabalin 
was associated with increased brightness induction; the use 
of valproate, lamotrigine or pregabalin was associated with 
decreased contrast suppression (Table 2, β coefficients). 
Most of the patient group (n = 74) replicated the contrast 
tests in a follow-up measurement. Approximately half of the 
patients were in remission (no MDE criterion symptoms) at 
the end of follow-up (borderline personality disorder 52.2%, 
bipolar disorder 60.6%, MDD 56.4%). To assess the recovery 
of contrast perception, we calculated the change in test scores 
for brightness induction and contrast suppression by sub-
tracting the baseline scores from the follow-up scores, and we 
compared these to the change in MADRS scores. The correla-
tion between MADRS score and change in brightness induc-
tion was as follows: r67 = 0.073, p = 0.556 (Figure 4, top). The 
correlation between MADRS score and change in contrast 
suppression was as follows: r73 = –0.156, p = 0.189 (Figrue 4, 
bottom). The negative correlation between the change in 
 contrast suppression and MADRS score indicates that a 
decrease in depression symptoms was associated with an 
 increase in contrast suppression. The correlations were mod-
est, but we found stronger correlations for contrast suppres-
sion than for brightness induction.
Finally, we performed sensitivity and specificity analyses 
with our sample to evaluate the classification accuracy and 
systematicity of changes in brightness induction and contrast 
suppression at the individual participant level. Using the 
mean of the controls as a cut-off point, the sensitivity of the 
contrast suppression test was 79% and the specificity was 45%. 
Using an optimal cut-off point based on receiver operating 
Fig. 3: Effect of (A) diagnostic subgroup and (B) medication on the strength of brightness induction (top) and contrast suppression 
(bottom). The error bars depict standard errors of the mean. BD = bipolar disorder; BPD = borderline personality disorder; MDD = major 
depressive disorder.
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characteristic analysis,30 the sensitivity was 50% and the 
speci ficity was 62%. The area under the curve was 0.66.
Discussion
We assessed visual perception in patients experiencing a 
 major depressive episode and healthy controls using 2 con-
trast tests that reflected the retinal and cortical processing of 
contrast information. In the brightness induction test, we 
measured the effect of surround luminance on perceived 
 luminance; in the contrast suppression test, we measured the 
effect of collinear surround on perceived contrast. When 
comparing the patient group with controls, we observed a 
strong and highly significant reduction in contrast suppres-
sion but not in brightness induction. Both patients and con-
trols perceived the brightness induction illusion similarly, 
but patients perceived the contrast suppression illusion more 
veridically. Because contrast suppression is orientation-specific 
and relies on cortical processing, our results suggest that 
 people experiencing a major depressive episode have nor-
mal retinal processing but altered cortical contrast normaliza-
tion. Furthermore, contrast suppression was similarly re-
duced in patients with unipolar MDD, bipolar disorder and 
borderline personality disorder.
Contrast suppression in the primary visual cortex is 
achieved via the interaction of 2 mechanisms: an excitatory 
feedforward signal (originating from the retina) and an inhib-
itory feedback signal (from higher cortical areas), both of 
which have different thresholds and gains.31–33 Therefore, re-
duced contrast suppression might be caused by lower retinal 
contrast gain or by a decreased amount of feedback. The for-
mer possibility is supported by previous reports of decreased 
retinal gain in depression.1,3–5,7 The latter possibility is sup-
ported by reports suggesting changes in processing in the 
visual cortex in MDD.8,9 We assessed both retinal and cortical 
contrast processing in the same sample of patients using 
2 behavioural tests that depended differently on cortical (i.e., 
orientation-specific) processing. We observed no difference 
in the brightness induction test; thus, our results support 
altered feedback as the explanation for the reduced contrast 
suppression.
We had a relatively large sample of patients that we di-
vided into 3 subgroups. Interestingly, we found a highly 
similar reduction in contrast suppression during an MDE 
for patients with unipolar depression, patients with bipolar 
disorder and patients with borderline personality disorder. 
The reduction in contrast suppression was strongest for 
patients with borderline personality disorder, followed by 
patients with bipolar disorder and then patients with unipo-
lar MDD. However, this trend was not statistically signifi-
cant, so our results suggest similar changes in visual contrast 
processing for the 3 subgroups. Contrast suppression in the 
patient group had not normalized completely by the follow-
up measurement, although we did observe some recovery 
and found a trend for an association between recovery of 
contrast suppression and change in MADRS score.
The inhibitory signals in centre-surround effects could be 
mediated via γ-aminobutyric acid (GABA)-ergic interneur-
ons.34 Previous studies have shown reduced GABA and glu-
tamate function in patients with MDD.35–38 Thus, if GABA or 
glutamate neurons (or both) mediate a centre-surround inter-
action, their dysfunction might explain the reduced contrast 
suppression we observed. The use of mood stabilizers may 
affect contrast perception. The use of lamotrigine, valproate 
or pregabalin was associated with increased brightness in-
duction, and the use of valproate, lamotrigine or pregabalin 
was associated with decreased contrast suppression. 
 Lamotrigine acts on voltage-sensitive sodium channels to 
 stabilize neuronal membranes and inhibit glutamate release. It 
has no direct effect on GABA neurons. Valproate, on the other 
hand, is an inhibitor of GABA transaminase, the major cata-
bolic enzyme of GABA, leading to increased concentrations of 
Table 2: Medication use* in the patient group
Medication 






(78) β p value β p value
Valproate 0.29 0.10 0.03 0.060 0.58 –0.369 0.001§
Lamotrigine 0.43 0.14 0.05 0.136 0.18 –0.072 0.45
Pregabalin 0.29 — 0.05 0.054 0.63 –0.076 0.47
Benzodiazepine 0.07 0.05 0.05 0.040 0.71 0.060 0.55
SSRI, SARI or SMS 0.36 0.43 0.68 –0.103 0.35 –0.092 0.37
SNRI or tricyclic antidepressant 0.36 0.14 0.32 –0.001 0.99 –0.036 0.75
Tetracyclic antidepressant 0.07 — 0.10 –0.039 0.70 –0.036 0.71
NDRI — 0.05 0.06 –0.032 0.75 –0.027 0.78
Agomelatine — — 0.01 –0.042 0.68 –0.029 0.77
Other 0.07 0.05 0.03 0.023 0.82 0.116 0.24
NDRI = norepinephrine–dopamine reuptake inhibitor; SARI = serotonin antagonist and reuptake inhibitor; SMS = serotonin modulator and stimulator (vortioxetine); 
SNRI = serotonin-norepinephrine reuptake inhibitor; SSRI = selective serotonin reuptake inhibitor.
*Nineteen patients used no medication. Some patients used multiple medications.
†Proportion of patients using the medication in each subgroup.
‡Brightness induction and contrast suppression β coefficients and p values are from linear regression analysis.
§p < 0.01.
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GABA. Pregabalin has no direct effects on GABA transmis-
sion, but it reduces the release of glutamate. Thus, the associ-
ation of these medications with brightness induction and 
contrast suppression scores might support a role for GABA 
or glutamate in mediating reduced contrast suppression, 
 although these relationships are complex and should be 
 interpreted with caution.
A reduction in contrast suppression similar to what we 
reported has been shown in people with schizophrenia and 
bipolar disorder.29,39 These patient groups showed reduced 
contrast suppression and thus more veridical perception than 
controls. Furthermore, dissociation of luminance and contrast, 
akin to our observation in MDEs, has also been reported in 
schizophrenia.40 This suggests that changes in visual process-
ing may be a general feature of many psychopathologies. In 
schizophrenia, a reduction in contrast suppression is associ-
ated with GABA concentrations.41
Changes in surround suppression of visual motion has been 
found in MDD8 and schizophrenia.42 In MDD,8 the amount of 
surround suppression depends on the contrast level: suppres-
sion is reduced at low contrast levels and increased at high 
contrast levels. We tested only 1 contrast level, so we could 
not directly compare our results for contrast-dependent 
 motion suppression. However, because contrast normalization 
is dysfunctional in depression, an interaction of contrast level 
and suppression strength could be expected. Centre-surround 
effects of visual motion and contrast have common properties, 
and both seem to be reduced in MDD and schizophrenia. 
However, in a healthy population, contrast and motion sup-
pression are not correlated and thus might be mediated via 
different neural mechanisms.43 In future studies, systematic 
 effects of contrast level and contrast- and motion-related sur-
round suppression in depression should be further investi-
gated to test whether contrast suppression could serve as a 
biomarker for changes in visual processing during MDEs.
Limitations
In previous studies, retinal contrast gain was assessed using 
pattern retinogram3 and by behavioural measurement of con-
trast detection thresholds.6 We assessed retinal contrast gain 
using a brightness induction test. Because of retinal normal-
ization of overall luminance level, only the contrast signal at 
the luminance border is passed to the visual cortex; that con-
trast signal is used to compute the brightness of the whole 
surface, and the contrast spreads or fills the whole surface.15 
Thus, perceived brightness in the brightness induction test is 
determined both by (retinal) contrast at the luminance border 
and (cortical) filling of the surface. In theory, if retinal con-
trast gain is reduced, the cortical filling-in mechanism could 
compensate and retinal reduction would not be visible in the 
brightness induction test.
We measured visual perception using behavioural tests, 
which are subjective in nature. Although we controlled for 
the subjectivity of the tests with the psychophysical method 
(e.g., randomly interleaving stimuli), patients might still 
have had (for example) lower vigilance than controls, and 
this could have explained some differences. However, be-
cause we had 2 tests (brightness induction and contrast sup-
pression) with a highly similar structure, it is unlikely that 
any general difference would explain the result specific to 
contrast suppression we observed. One limitation in our 
study was that we could infer retinal and cortical processing 
only indirectly using behavioural tests. More direct evidence 
on the neural loci of differences in visual perception could 
be assessed using PERG or EEG. In future studies, both 
PERG or EEG and different contrast tests should be con-
ducted in the same sample of patients to resolve the exact 
neural cause of the reduced contrast suppression in MDEs.
Fig. 4: Follow-up results. The change in brightness induction 
(top) and contrast suppression (bottom) test scores at the end of 
follow-up plotted against the change in MADRS scores at the 
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There was a difference in our sample sizes (111 patients, 
29 controls), but we controlled for this difference by using 
the Welch t test and comparing each patient subgroup to 
controls separately. Additional differences between controls 
and patients were employment status and level of education. 
However, because we assessed low-level visual processing, 
these differences were not likely to explain our results.
Our results were clear at the group level, but we found 
considerable variability in individual performances on the 
contrast tests. The preliminary sensitivity and specificity 
 values we obtained were quite low, and follow-up effects 
were modest. To use behavioural contrast tests as biomark-
ers, the tests could be improved by reducing measurement 
noise, for example, by increasing the number of trials and 
measurement blocks.
Conclusion
Using 2 visual contrast tests in a large sample of patients, we 
showed that cortical contrast suppression was reduced dur-
ing MDEs and retinal brightness induction was intact. We 
found this deficit patients with unipolar MDD, bipolar disor-
der and borderline personality disorder. Combined with the 
findings of previous studies, it appears that MDEs involve 
changes at different levels in the visual processing hierarchy, 
from retina to cortex. From a practical point of view, visual 
contrast tests are a rapid, simple and noninvasive method 
that could be further developed to serve as biomarkers for 
the abnormal processing of visual information in depression.
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